METFORMIN 500mg. IP

An anti-diabetic medicine used in the treatment of type 2 diabetes mellitus. A first-line pharmacological treatment for patients with type 2 diabetes mellitus. (Serge Jabbour, 2011) Possesses glucose-lowering ability, weight-neutral effects, and a low risk of hypoglycemia. (Serge Jabbour, 2011) An effective treatment for type 2 diabetes mellitus. (Peter Timmins, 2003) Effectively reduces the glycosylated Hemoglobin (HbA1c) and decreases microvascular and macrovascular disease. (L A Donnelly, 2009) A cost-saving alternative to metformin immediate release for the treatment of type 2 diabetes. (Judith J. Gout-Zwart, 2020) Enhances patient compliance and improves long-term control of diabetes compared with the conventional immediate-release formulation of metformin. (Ken Fujioka, 2003) An attractive option to a conventional immediate-release tablet for adults with type 2 diabetes. (Chang Liu, 2021) Ameliorates glycemic control in patients with type 2 diabetes. (Traci E LaMoia, 2021) A valuable drug for the treatment of type 2 diabetes. (C.R, 2015) Has better gastrointestinal tolerability and fewer side effects as compared to Metformin immediate release. (Maliha Hameed, 2017)